

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 8.29556786 |
| 2 | desmosome organization (GO:0002934) | 8.13771519 |
| 3 | positive regulation of cellular amide metabolic process (GO:0034250) | 8.00916763 |
| 4 | regulation of water loss via skin (GO:0033561) | 7.64052209 |
| 5 | keratinization (GO:0031424) | 6.42546100 |
| 6 | molting cycle (GO:0042303) | 5.81970691 |
| 7 | hair cycle (GO:0042633) | 5.81970691 |
| 8 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.70036852 |
| 9 | positive regulation of interleukin-8 secretion (GO:2000484) | 5.67256610 |
| 10 | xenobiotic catabolic process (GO:0042178) | 5.54035145 |
| 11 | multicellular organismal water homeostasis (GO:0050891) | 5.40260213 |
| 12 | response to nitrosative stress (GO:0051409) | 5.39296861 |
| 13 | hemidesmosome assembly (GO:0031581) | 5.28286496 |
| 14 | cellular glucuronidation (GO:0052695) | 5.14828030 |
| 15 | hormone catabolic process (GO:0042447) | 4.98302836 |
| 16 | uronic acid metabolic process (GO:0006063) | 4.91830149 |
| 17 | glucuronate metabolic process (GO:0019585) | 4.91830149 |
| 18 | positive regulation of humoral immune response (GO:0002922) | 4.74701537 |
| 19 | water homeostasis (GO:0030104) | 4.70453780 |
| 20 | phospholipid efflux (GO:0033700) | 4.64873758 |
| 21 | regulation of cellular amide metabolic process (GO:0034248) | 4.63180057 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25939058 |
| 23 | linoleic acid metabolic process (GO:0043651) | 4.23827976 |
| 24 | defense response to Gram-negative bacterium (GO:0050829) | 4.21874693 |
| 25 | keratinocyte differentiation (GO:0030216) | 4.14945135 |
| 26 | glutathione derivative metabolic process (GO:1901685) | 4.10961991 |
| 27 | glutathione derivative biosynthetic process (GO:1901687) | 4.10961991 |
| 28 | dendritic cell migration (GO:0036336) | 4.08949100 |
| 29 | surfactant homeostasis (GO:0043129) | 4.00823420 |
| 30 | regulation of interleukin-8 secretion (GO:2000482) | 3.99742519 |
| 31 | detection of bacterium (GO:0016045) | 3.98647520 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 3.94819337 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 3.92733232 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.86748644 |
| 35 | chemical homeostasis within a tissue (GO:0048875) | 3.85437378 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.84405136 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.80666499 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 3.80666499 |
| 39 | peptide cross-linking (GO:0018149) | 3.78272783 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.73824810 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.73824810 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 3.73824810 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.73824810 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.73824810 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.73824810 |
| 46 | intestinal cholesterol absorption (GO:0030299) | 3.70274492 |
| 47 | peptide catabolic process (GO:0043171) | 3.60248592 |
| 48 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.59924895 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 3.57930176 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.57930176 |
| 51 | negative regulation of lipase activity (GO:0060192) | 3.56514048 |
| 52 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.53781707 |
| 53 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.53781707 |
| 54 | reverse cholesterol transport (GO:0043691) | 3.53751884 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52425876 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.49628791 |
| 57 | benzene-containing compound metabolic process (GO:0042537) | 3.47990900 |
| 58 | fatty acid elongation (GO:0030497) | 3.46231180 |
| 59 | detection of other organism (GO:0098543) | 3.46134486 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.42942147 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.42942147 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.42942147 |
| 63 | regulation of phospholipase A2 activity (GO:0032429) | 3.42777826 |
| 64 | regulation of cholesterol homeostasis (GO:2000188) | 3.41480842 |
| 65 | defense response to fungus (GO:0050832) | 3.38765176 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 3.36781813 |
| 67 | epidermal cell differentiation (GO:0009913) | 3.35568361 |
| 68 | intermediate filament organization (GO:0045109) | 3.34858337 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.34016349 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.33899385 |
| 71 | negative regulation of cell killing (GO:0031342) | 3.33899385 |
| 72 | epidermis development (GO:0008544) | 3.33855600 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 3.32527401 |
| 74 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.26049045 |
| 75 | detection of biotic stimulus (GO:0009595) | 3.24402402 |
| 76 | cysteine metabolic process (GO:0006534) | 3.23539512 |
| 77 | aromatic amino acid family catabolic process (GO:0009074) | 3.23480527 |
| 78 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.23381990 |
| 79 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.22536123 |
| 80 | alpha-linolenic acid metabolic process (GO:0036109) | 3.21884985 |
| 81 | positive regulation of p38MAPK cascade (GO:1900745) | 3.21143830 |
| 82 | negative regulation of interleukin-17 production (GO:0032700) | 3.20351216 |
| 83 | response to peptidoglycan (GO:0032494) | 3.18442592 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18159305 |
| 85 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15695887 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.14704356 |
| 87 | one-carbon compound transport (GO:0019755) | 3.12290253 |
| 88 | hypotonic response (GO:0006971) | 3.11975677 |
| 89 | glutathione metabolic process (GO:0006749) | 3.10491876 |
| 90 | bile acid biosynthetic process (GO:0006699) | 3.09185382 |
| 91 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.08729159 |
| 92 | bile acid metabolic process (GO:0008206) | 3.08398546 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.08295467 |
| 94 | very long-chain fatty acid metabolic process (GO:0000038) | 3.05568231 |
| 95 | natural killer cell activation involved in immune response (GO:0002323) | 3.04146810 |
| 96 | amino-acid betaine metabolic process (GO:0006577) | 3.02642459 |
| 97 | negative regulation of sterol transport (GO:0032372) | 3.02570195 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 3.02570195 |
| 99 | flavonoid metabolic process (GO:0009812) | 3.01938528 |
| 100 | cholesterol efflux (GO:0033344) | 3.00083972 |
| 101 | glyoxylate metabolic process (GO:0046487) | 2.96954055 |
| 102 | L-ascorbic acid metabolic process (GO:0019852) | 2.95942489 |
| 103 | atrioventricular valve morphogenesis (GO:0003181) | 2.95849160 |
| 104 | skin morphogenesis (GO:0043589) | 2.92897630 |
| 105 | protein carboxylation (GO:0018214) | 2.92099036 |
| 106 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.92099036 |
| 107 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.89991899 |
| 108 | regulation of triglyceride catabolic process (GO:0010896) | 2.89530278 |
| 109 | positive regulation of glomerulus development (GO:0090193) | 2.85775830 |
| 110 | kynurenine metabolic process (GO:0070189) | 2.84192889 |
| 111 | keratinocyte proliferation (GO:0043616) | 2.84125888 |
| 112 | ectoderm development (GO:0007398) | 2.83702922 |
| 113 | tryptophan catabolic process (GO:0006569) | 2.83677704 |
| 114 | indole-containing compound catabolic process (GO:0042436) | 2.83677704 |
| 115 | indolalkylamine catabolic process (GO:0046218) | 2.83677704 |
| 116 | fibrinolysis (GO:0042730) | 2.83227560 |
| 117 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.83056124 |
| 118 | renal absorption (GO:0070293) | 2.82733409 |
| 119 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82626247 |
| 120 | triglyceride homeostasis (GO:0070328) | 2.82380549 |
| 121 | acylglycerol homeostasis (GO:0055090) | 2.82380549 |
| 122 | lipoxygenase pathway (GO:0019372) | 2.80902538 |
| 123 | regulation of transforming growth factor beta production (GO:0071634) | 2.80533141 |
| 124 | neutrophil activation (GO:0042119) | 2.79681302 |
| 125 | positive regulation of sterol transport (GO:0032373) | 2.79423550 |
| 126 | positive regulation of cholesterol transport (GO:0032376) | 2.79423550 |
| 127 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.78791147 |
| 128 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.78791147 |
| 129 | urea metabolic process (GO:0019627) | 2.78144759 |
| 130 | urea cycle (GO:0000050) | 2.78144759 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 2.77742584 |
| 132 | positive regulation of epidermis development (GO:0045684) | 2.77265930 |
| 133 | response to fungus (GO:0009620) | 2.76847837 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76139377 |
| 135 | iron ion import (GO:0097286) | 2.72372795 |
| 136 | negative regulation of fibrinolysis (GO:0051918) | 2.72313029 |
| 137 | positive regulation of cholesterol efflux (GO:0010875) | 2.71564702 |
| 138 | primary alcohol catabolic process (GO:0034310) | 2.71144211 |
| 139 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.69526764 |
| 140 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.68971367 |
| 141 | keratinocyte development (GO:0003334) | 2.68543225 |
| 142 | ethanol metabolic process (GO:0006067) | 2.67498190 |
| 143 | regulation of fibrinolysis (GO:0051917) | 2.67359740 |
| 144 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.67165975 |
| 145 | diterpenoid biosynthetic process (GO:0016102) | 2.66181327 |
| 146 | tryptophan metabolic process (GO:0006568) | 2.66148202 |
| 147 | macrophage activation (GO:0042116) | 2.64638236 |
| 148 | antimicrobial humoral response (GO:0019730) | 2.64466280 |
| 149 | positive regulation of interleukin-6 production (GO:0032755) | 2.64337855 |
| 150 | intestinal epithelial cell development (GO:0060576) | 2.62924040 |
| 151 | regulation of cholesterol metabolic process (GO:0090181) | 2.62444969 |
| 152 | regulation of T-helper 1 type immune response (GO:0002825) | 2.61821848 |
| 153 | granulocyte activation (GO:0036230) | 2.58679190 |
| 154 | regulation of interleukin-6 production (GO:0032675) | 2.58389600 |
| 155 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.57661996 |
| 156 | regulation of ruffle assembly (GO:1900027) | 2.57544739 |
| 157 | activation of MAPKKK activity (GO:0000185) | 2.56220855 |
| 158 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.55365423 |
| 159 | regulation of mast cell degranulation (GO:0043304) | 2.54205890 |
| 160 | response to host (GO:0075136) | 2.51866895 |
| 161 | response to host defenses (GO:0052200) | 2.51866895 |
| 162 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51866895 |
| 163 | microglial cell activation (GO:0001774) | 2.51465303 |
| 164 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50006009 |
| 165 | neutrophil mediated immunity (GO:0002446) | 2.47941228 |
| 166 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.46065815 |
| 167 | mammary gland epithelial cell proliferation (GO:0033598) | 2.45821228 |
| 168 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.45754331 |
| 169 | regulation of leukocyte degranulation (GO:0043300) | 2.45415356 |
| 170 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.44988898 |
| 171 | leukocyte aggregation (GO:0070486) | 2.43743798 |
| 172 | positive regulation of response to biotic stimulus (GO:0002833) | 2.43654022 |
| 173 | regulation of hair cycle (GO:0042634) | 2.41503264 |
| 174 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.40687776 |
| 175 | response to host immune response (GO:0052572) | 2.39958496 |
| 176 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.39958496 |
| 177 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.39009777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.08709060 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.06898615 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.05486103 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76807752 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.50798170 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18319859 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.16675267 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.95878032 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.73196565 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.70451817 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.59463747 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.46404011 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.42714063 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.33512967 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24845577 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20522132 |
| 17 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.17901064 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11852433 |
| 19 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.07979937 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03649052 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01592111 |
| 22 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.99375275 |
| 23 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.90330435 |
| 24 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.86160830 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80865009 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.78040164 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.77606401 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74876407 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73062014 |
| 30 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.71817766 |
| 31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.71486021 |
| 32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.71486021 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66086368 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63724088 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61821762 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60622951 |
| 37 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.60501330 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60380950 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56503482 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56462938 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55423205 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54403085 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51577315 |
| 44 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.51533008 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47983980 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47229363 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43202060 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.42058086 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41286907 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39835204 |
| 51 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38412711 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34943073 |
| 53 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.34413396 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34273845 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34010775 |
| 56 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.32808466 |
| 57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31908633 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27808106 |
| 59 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25269593 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24405622 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.23604248 |
| 62 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.21145879 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20354585 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19065313 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18338433 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18259936 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18106035 |
| 68 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17250151 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16740024 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16655970 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16172109 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15266768 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15126213 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.14549517 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14361319 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13827941 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12175462 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12131737 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11776295 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.11262425 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10981101 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09396187 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09374190 |
| 84 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07874354 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06776662 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06413100 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06022997 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05292331 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04412478 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04057523 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03308575 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02440885 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01832513 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01367120 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00840061 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00357840 |
| 97 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99822272 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97358626 |
| 99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96525602 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95272899 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94702451 |
| 102 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93351257 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93200735 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92842853 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92842853 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91940598 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91922078 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91761358 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90647668 |
| 110 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90559898 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90527130 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89132596 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88911203 |
| 114 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88747991 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87620564 |
| 116 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83705356 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83145981 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79754591 |
| 119 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79243935 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79229370 |
| 121 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.78909661 |
| 122 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78416067 |
| 123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78038161 |
| 124 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.77023847 |
| 125 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76167524 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75955912 |
| 127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.72666326 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.72294297 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70300577 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.69410746 |
| 131 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.69028193 |
| 132 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.68343230 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67907944 |
| 134 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.65795710 |
| 135 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.65795710 |
| 136 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.65795710 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.65530906 |
| 138 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.65374036 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.63271721 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.63271721 |
| 141 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.63037751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 5.86561937 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.01729368 |
| 3 | MP0005275_abnormal_skin_tensile | 3.89501732 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.82033506 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46608078 |
| 6 | MP0005501_abnormal_skin_physiology | 3.35240282 |
| 7 | MP0002254_reproductive_system_inflammat | 3.29950084 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.16147034 |
| 9 | MP0003941_abnormal_skin_development | 3.15237839 |
| 10 | MP0005451_abnormal_body_composition | 3.14770054 |
| 11 | MP0005365_abnormal_bile_salt | 2.82993183 |
| 12 | MP0002098_abnormal_vibrissa_morphology | 2.81872645 |
| 13 | MP0005360_urolithiasis | 2.73799474 |
| 14 | MP0003724_increased_susceptibility_to | 2.64833736 |
| 15 | MP0000579_abnormal_nail_morphology | 2.62735391 |
| 16 | MP0002060_abnormal_skin_morphology | 2.53536378 |
| 17 | MP0001216_abnormal_epidermal_layer | 2.43642514 |
| 18 | MP0010678_abnormal_skin_adnexa | 2.25410180 |
| 19 | MP0003436_decreased_susceptibility_to | 2.24522163 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.21556024 |
| 21 | MP0004947_skin_inflammation | 2.19794840 |
| 22 | MP0000647_abnormal_sebaceous_gland | 2.19589606 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.13466133 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.13406189 |
| 25 | MP0004381_abnormal_hair_follicle | 2.13284606 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.06973250 |
| 27 | MP0005083_abnormal_biliary_tract | 2.03756038 |
| 28 | MP0010771_integument_phenotype | 2.01635885 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.89218750 |
| 30 | MP0001346_abnormal_lacrimal_gland | 1.88207710 |
| 31 | MP0000383_abnormal_hair_follicle | 1.84958001 |
| 32 | MP0008260_abnormal_autophagy | 1.84905149 |
| 33 | MP0000377_abnormal_hair_follicle | 1.82374993 |
| 34 | MP0000762_abnormal_tongue_morphology | 1.80014248 |
| 35 | MP0010329_abnormal_lipoprotein_level | 1.79619341 |
| 36 | MP0000566_synostosis | 1.77578088 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.74242096 |
| 38 | MP0005499_abnormal_olfactory_system | 1.74242096 |
| 39 | MP0003252_abnormal_bile_duct | 1.68456777 |
| 40 | MP0000467_abnormal_esophagus_morphology | 1.68405546 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.66294678 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.66050676 |
| 43 | MP0009840_abnormal_foam_cell | 1.54796281 |
| 44 | MP0009053_abnormal_anal_canal | 1.54698790 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.48906889 |
| 46 | MP0003303_peritoneal_inflammation | 1.48887800 |
| 47 | MP0000427_abnormal_hair_cycle | 1.46398569 |
| 48 | MP0002419_abnormal_innate_immunity | 1.44583296 |
| 49 | MP0009785_altered_susceptibility_to | 1.44117459 |
| 50 | MP0005025_abnormal_response_to | 1.43084663 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.42888690 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.37567220 |
| 53 | MP0010030_abnormal_orbit_morphology | 1.35548658 |
| 54 | MP0003828_pulmonary_edema | 1.32256834 |
| 55 | MP0008004_abnormal_stomach_pH | 1.32243344 |
| 56 | MP0000858_altered_metastatic_potential | 1.32056172 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.29410446 |
| 58 | MP0000537_abnormal_urethra_morphology | 1.26045369 |
| 59 | MP0009931_abnormal_skin_appearance | 1.25837017 |
| 60 | MP0001191_abnormal_skin_condition | 1.24873347 |
| 61 | MP0000685_abnormal_immune_system | 1.24853618 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.22972035 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.22384383 |
| 64 | MP0001800_abnormal_humoral_immune | 1.21382801 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.20897968 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.17313969 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.15567051 |
| 68 | MP0004883_abnormal_blood_vessel | 1.14367601 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 1.13773307 |
| 70 | MP0005409_darkened_coat_color | 1.13467703 |
| 71 | MP0005164_abnormal_response_to | 1.12835669 |
| 72 | MP0001851_eye_inflammation | 1.12131528 |
| 73 | MP0002723_abnormal_immune_serum | 1.10140450 |
| 74 | MP0003878_abnormal_ear_physiology | 1.07112790 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 1.07112790 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.06858609 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.05525360 |
| 78 | MP0004510_myositis | 1.02944897 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.00726174 |
| 80 | MP0000367_abnormal_coat/_hair | 1.00215336 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.00094833 |
| 82 | MP0001835_abnormal_antigen_presentation | 0.99706631 |
| 83 | MP0001819_abnormal_immune_cell | 0.98962198 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.97563839 |
| 85 | MP0001243_abnormal_dermal_layer | 0.96678604 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 0.95590632 |
| 87 | MP0005023_abnormal_wound_healing | 0.95358251 |
| 88 | MP0002009_preneoplasia | 0.92709799 |
| 89 | MP0001790_abnormal_immune_system | 0.92402365 |
| 90 | MP0005387_immune_system_phenotype | 0.92402365 |
| 91 | MP0003866_abnormal_defecation | 0.90108028 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.88836928 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.88760172 |
| 94 | MP0003195_calcinosis | 0.88696242 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.88610003 |
| 96 | MP0005332_abnormal_amino_acid | 0.88279262 |
| 97 | MP0002405_respiratory_system_inflammati | 0.88273730 |
| 98 | MP0002148_abnormal_hypersensitivity_rea | 0.88210594 |
| 99 | MP0002132_abnormal_respiratory_system | 0.87996823 |
| 100 | MP0003011_delayed_dark_adaptation | 0.87799184 |
| 101 | MP0001984_abnormal_olfaction | 0.87388058 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.87065533 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.86345015 |
| 104 | MP0003448_altered_tumor_morphology | 0.86266995 |
| 105 | MP0000609_abnormal_liver_physiology | 0.81869882 |
| 106 | MP0001873_stomach_inflammation | 0.80392762 |
| 107 | MP0002233_abnormal_nose_morphology | 0.78803687 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.77858793 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77562897 |
| 110 | MP0000613_abnormal_salivary_gland | 0.77209157 |
| 111 | MP0002249_abnormal_larynx_morphology | 0.77007489 |
| 112 | MP0006082_CNS_inflammation | 0.76316065 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.72053119 |
| 114 | MP0003186_abnormal_redox_activity | 0.70823213 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.70414504 |
| 116 | MP0003045_fibrosis | 0.70134755 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.68677276 |
| 118 | MP0002090_abnormal_vision | 0.66617676 |
| 119 | MP0003300_gastrointestinal_ulcer | 0.65588930 |
| 120 | MP0003091_abnormal_cell_migration | 0.65560195 |
| 121 | MP0000716_abnormal_immune_system | 0.65376084 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.64732319 |
| 123 | MP0005408_hypopigmentation | 0.64575541 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.63017155 |
| 125 | MP0005166_decreased_susceptibility_to | 0.62840114 |
| 126 | MP0001340_abnormal_eyelid_morphology | 0.61805178 |
| 127 | MP0005647_abnormal_sex_gland | 0.61802134 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.60694381 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.59711296 |
| 130 | MP0002282_abnormal_trachea_morphology | 0.59605096 |
| 131 | MP0003868_abnormal_feces_composition | 0.59508895 |
| 132 | MP0002398_abnormal_bone_marrow | 0.57763598 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.57698661 |
| 134 | MP0009764_decreased_sensitivity_to | 0.57565874 |
| 135 | MP0004858_abnormal_nervous_system | 0.57415306 |
| 136 | MP0005220_abnormal_exocrine_pancreas | 0.53974444 |
| 137 | MP0001849_ear_inflammation | 0.52991980 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.52572726 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.51479156 |
| 140 | MP0000627_abnormal_mammary_gland | 0.51136232 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.49487279 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.48429857 |
| 143 | MP0009643_abnormal_urine_homeostasis | 0.47492544 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.45367338 |
| 145 | MP0003950_abnormal_plasma_membrane | 0.44903588 |
| 146 | MP0004272_abnormal_basement_membrane | 0.42227354 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.42103530 |
| 148 | MP0003075_altered_response_to | 0.41924207 |
| 149 | MP0010155_abnormal_intestine_physiology | 0.40910038 |
| 150 | MP0001177_atelectasis | 0.39852236 |
| 151 | MP0005367_renal/urinary_system_phenotyp | 0.39288295 |
| 152 | MP0000516_abnormal_urinary_system | 0.39288295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.72036622 |
| 2 | Hypotrichosis (HP:0001006) | 5.43220886 |
| 3 | Woolly hair (HP:0002224) | 5.41483870 |
| 4 | Onycholysis (HP:0001806) | 5.33593450 |
| 5 | Plantar hyperkeratosis (HP:0007556) | 5.04425697 |
| 6 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.92392241 |
| 7 | Fragile nails (HP:0001808) | 4.87593559 |
| 8 | Lip pit (HP:0100267) | 4.56170754 |
| 9 | Increased IgE level (HP:0003212) | 4.47536686 |
| 10 | Palmoplantar hyperkeratosis (HP:0000972) | 4.37817219 |
| 11 | Abnormality of nail color (HP:0100643) | 4.31139974 |
| 12 | Palmar hyperkeratosis (HP:0010765) | 4.16153712 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.04645171 |
| 14 | Milia (HP:0001056) | 3.85826266 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.79026424 |
| 16 | Alopecia of scalp (HP:0002293) | 3.77382207 |
| 17 | Nail dystrophy (HP:0008404) | 3.69334260 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.67306312 |
| 19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.57830390 |
| 20 | Xanthomatosis (HP:0000991) | 3.55053537 |
| 21 | Curly hair (HP:0002212) | 3.47575393 |
| 22 | Erythroderma (HP:0001019) | 3.37381994 |
| 23 | Erythema (HP:0010783) | 3.36587940 |
| 24 | Follicular hyperkeratosis (HP:0007502) | 3.26239207 |
| 25 | Oral leukoplakia (HP:0002745) | 3.25587968 |
| 26 | Pili torti (HP:0003777) | 3.19946623 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.15755475 |
| 28 | Orchitis (HP:0100796) | 3.15353337 |
| 29 | Myositis (HP:0100614) | 3.09702408 |
| 30 | Thick nail (HP:0001805) | 3.09332474 |
| 31 | Hypobetalipoproteinemia (HP:0003563) | 3.00110858 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.99696008 |
| 33 | Corneal erosion (HP:0200020) | 2.95951803 |
| 34 | Abnormality of macrophages (HP:0004311) | 2.95112269 |
| 35 | Abnormal blistering of the skin (HP:0008066) | 2.91600561 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.90759211 |
| 37 | Pruritus (HP:0000989) | 2.87805360 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.86329755 |
| 39 | Optic neuritis (HP:0100653) | 2.86329755 |
| 40 | Gangrene (HP:0100758) | 2.84183753 |
| 41 | Epidermoid cyst (HP:0200040) | 2.83045712 |
| 42 | Prolonged partial thromboplastin time (HP:0003645) | 2.80728457 |
| 43 | Ectropion (HP:0000656) | 2.71389165 |
| 44 | Fat malabsorption (HP:0002630) | 2.68280238 |
| 45 | Bifid scrotum (HP:0000048) | 2.67058324 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 2.66644833 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.64721820 |
| 48 | Urticaria (HP:0001025) | 2.64624969 |
| 49 | Atrophic scars (HP:0001075) | 2.64128695 |
| 50 | Ventricular tachycardia (HP:0004756) | 2.62599806 |
| 51 | Hypolipoproteinemia (HP:0010981) | 2.56741539 |
| 52 | Natal tooth (HP:0000695) | 2.56434115 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.54320191 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52882204 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.52568623 |
| 56 | Advanced eruption of teeth (HP:0006288) | 2.48416595 |
| 57 | Hyporeflexia of lower limbs (HP:0002600) | 2.46142682 |
| 58 | Brittle hair (HP:0002299) | 2.42046337 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.39968728 |
| 60 | Parakeratosis (HP:0001036) | 2.39156403 |
| 61 | Acanthosis nigricans (HP:0000956) | 2.37997230 |
| 62 | Humeroradial synostosis (HP:0003041) | 2.37701289 |
| 63 | Synostosis involving the elbow (HP:0003938) | 2.37701289 |
| 64 | Sparse eyelashes (HP:0000653) | 2.36453460 |
| 65 | Palmoplantar keratoderma (HP:0000982) | 2.36336094 |
| 66 | Dehydration (HP:0001944) | 2.32011147 |
| 67 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30201746 |
| 68 | Abnormality of the salivary glands (HP:0010286) | 2.29037872 |
| 69 | Skin ulcer (HP:0200042) | 2.28603890 |
| 70 | Recurrent skin infections (HP:0001581) | 2.27269496 |
| 71 | Gingivitis (HP:0000230) | 2.26436122 |
| 72 | Subacute progressive viral hepatitis (HP:0006572) | 2.26156187 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.24306375 |
| 74 | Gout (HP:0001997) | 2.24059429 |
| 75 | Hypohidrosis (HP:0000966) | 2.22673893 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.22562561 |
| 77 | Abnormal hair laboratory examination (HP:0003328) | 2.21068376 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20041637 |
| 79 | Conjunctival hamartoma (HP:0100780) | 2.20026202 |
| 80 | Steatorrhea (HP:0002570) | 2.19450236 |
| 81 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.15242280 |
| 82 | Stenosis of the external auditory canal (HP:0000402) | 2.14886982 |
| 83 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.14321075 |
| 84 | Hypophosphatemic rickets (HP:0004912) | 2.13192097 |
| 85 | Hyperhidrosis (HP:0000975) | 2.12182186 |
| 86 | Abnormality of the gastric mucosa (HP:0004295) | 2.11324194 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10146893 |
| 88 | Vascular calcification (HP:0004934) | 2.09820391 |
| 89 | Malnutrition (HP:0004395) | 2.09394528 |
| 90 | Hypercholesterolemia (HP:0003124) | 2.06736186 |
| 91 | Ridged nail (HP:0001807) | 2.05307386 |
| 92 | Sparse scalp hair (HP:0002209) | 2.04057459 |
| 93 | Congenital, generalized hypertrichosis (HP:0004540) | 2.02426942 |
| 94 | Eczematoid dermatitis (HP:0000976) | 2.02192413 |
| 95 | Sepsis (HP:0100806) | 2.01720135 |
| 96 | Abnormality of the axillary hair (HP:0100134) | 2.01631281 |
| 97 | Abnormality of secondary sexual hair (HP:0009888) | 2.01631281 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.01096584 |
| 99 | Esophageal varix (HP:0002040) | 2.00828302 |
| 100 | Arterial tortuosity (HP:0005116) | 1.98328583 |
| 101 | Hyperglycinuria (HP:0003108) | 1.97058767 |
| 102 | Villous atrophy (HP:0011473) | 1.95925338 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95925338 |
| 104 | Corneal dystrophy (HP:0001131) | 1.95251201 |
| 105 | Stomatitis (HP:0010280) | 1.93861043 |
| 106 | Gingival bleeding (HP:0000225) | 1.89458375 |
| 107 | Increased serum ferritin (HP:0003281) | 1.89198335 |
| 108 | Pustule (HP:0200039) | 1.87959117 |
| 109 | Rickets (HP:0002748) | 1.87801518 |
| 110 | Mediastinal lymphadenopathy (HP:0100721) | 1.87773384 |
| 111 | Complement deficiency (HP:0004431) | 1.87621493 |
| 112 | Cardiovascular calcification (HP:0011915) | 1.86514130 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84466668 |
| 114 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.84013698 |
| 115 | Abnormality of the 2nd finger (HP:0004100) | 1.82625663 |
| 116 | Hypoglycemic coma (HP:0001325) | 1.82483262 |
| 117 | Abnormality of purine metabolism (HP:0004352) | 1.82399632 |
| 118 | Laryngomalacia (HP:0001601) | 1.81872453 |
| 119 | Abnormal hemoglobin (HP:0011902) | 1.81507476 |
| 120 | Ketosis (HP:0001946) | 1.80542851 |
| 121 | Abnormality of the common coagulation pathway (HP:0010990) | 1.80401370 |
| 122 | Popliteal pterygium (HP:0009756) | 1.80367224 |
| 123 | Hyperammonemia (HP:0001987) | 1.80005299 |
| 124 | Abnormal tarsal ossification (HP:0008369) | 1.79374648 |
| 125 | Joint hemorrhage (HP:0005261) | 1.78874964 |
| 126 | Alveolar cell carcinoma (HP:0006519) | 1.77209320 |
| 127 | Lack of skin elasticity (HP:0100679) | 1.76132241 |
| 128 | Hypoplastic labia majora (HP:0000059) | 1.76012070 |
| 129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74732862 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.74191631 |
| 131 | Amyloidosis (HP:0011034) | 1.73947043 |
| 132 | Papilloma (HP:0012740) | 1.72441135 |
| 133 | Verrucae (HP:0200043) | 1.72441135 |
| 134 | Blepharitis (HP:0000498) | 1.71989836 |
| 135 | Glomerulosclerosis (HP:0000096) | 1.71655440 |
| 136 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.71503100 |
| 137 | Abnormality of glycine metabolism (HP:0010895) | 1.71079339 |
| 138 | Prolonged bleeding time (HP:0003010) | 1.70469020 |
| 139 | Hypochromic anemia (HP:0001931) | 1.68719967 |
| 140 | Hypochromic microcytic anemia (HP:0004840) | 1.67071350 |
| 141 | Premature loss of primary teeth (HP:0006323) | 1.66564214 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.64826769 |
| 143 | Nasal polyposis (HP:0100582) | 1.62209479 |
| 144 | Oligodontia (HP:0000677) | 1.61618962 |
| 145 | Peritonitis (HP:0002586) | 1.61585849 |
| 146 | Vascular tortuosity (HP:0004948) | 1.60104793 |
| 147 | Cellulitis (HP:0100658) | 1.59205771 |
| 148 | Menorrhagia (HP:0000132) | 1.58482736 |
| 149 | Cheilitis (HP:0100825) | 1.57876479 |
| 150 | Micronodular cirrhosis (HP:0001413) | 1.57552784 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.55793257 |
| 152 | Obstructive lung disease (HP:0006536) | 1.55793257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.11864206 |
| 2 | EPHA2 | 3.95419922 |
| 3 | MST1R | 3.74630530 |
| 4 | MAPKAPK3 | 3.42141182 |
| 5 | MAP3K3 | 3.20292526 |
| 6 | ERN1 | 2.97926605 |
| 7 | EPHB2 | 2.78911572 |
| 8 | MAP3K2 | 2.71628942 |
| 9 | LATS1 | 2.69228419 |
| 10 | IRAK4 | 2.67184223 |
| 11 | BCKDK | 2.51373059 |
| 12 | RPS6KB2 | 2.47857876 |
| 13 | FRK | 2.47773225 |
| 14 | FER | 2.38911903 |
| 15 | SIK1 | 1.87215691 |
| 16 | RIPK4 | 1.86065851 |
| 17 | MAP2K2 | 1.83419257 |
| 18 | CSK | 1.78036412 |
| 19 | RIPK1 | 1.75890133 |
| 20 | CDK6 | 1.69307175 |
| 21 | FGFR4 | 1.58869814 |
| 22 | MET | 1.56309102 |
| 23 | IRAK1 | 1.48238202 |
| 24 | GRK6 | 1.42393275 |
| 25 | STK10 | 1.40918065 |
| 26 | ZAP70 | 1.39451143 |
| 27 | MAPK15 | 1.37197879 |
| 28 | PTK6 | 1.37159429 |
| 29 | IRAK2 | 1.35039020 |
| 30 | BLK | 1.34745138 |
| 31 | STK38L | 1.31870822 |
| 32 | MAP3K6 | 1.31746611 |
| 33 | PIK3CG | 1.31083177 |
| 34 | STK38 | 1.29099458 |
| 35 | MAP2K1 | 1.27086056 |
| 36 | ERBB4 | 1.25031601 |
| 37 | LRRK2 | 1.24766823 |
| 38 | TRPM7 | 1.22909205 |
| 39 | INSRR | 1.22606454 |
| 40 | TAOK1 | 1.20502799 |
| 41 | MAP2K6 | 1.16181543 |
| 42 | FGR | 1.13539331 |
| 43 | GRK1 | 1.13498629 |
| 44 | TESK1 | 1.13338017 |
| 45 | HCK | 1.09227582 |
| 46 | MAP3K7 | 1.04920087 |
| 47 | PTK2 | 1.04593350 |
| 48 | STK24 | 1.04589247 |
| 49 | TAOK3 | 1.03012226 |
| 50 | MAP3K12 | 1.01723368 |
| 51 | TRIB3 | 1.01669813 |
| 52 | MAP4K1 | 1.01276371 |
| 53 | SIK3 | 1.01169550 |
| 54 | TNK2 | 0.99753722 |
| 55 | EPHB1 | 0.99159578 |
| 56 | MARK2 | 0.98682266 |
| 57 | FGFR1 | 0.98038315 |
| 58 | MAP2K3 | 0.97945019 |
| 59 | DYRK3 | 0.97614466 |
| 60 | LMTK2 | 0.96139547 |
| 61 | PAK3 | 0.89502435 |
| 62 | BTK | 0.87994299 |
| 63 | EPHA3 | 0.86237529 |
| 64 | TTN | 0.85673826 |
| 65 | YES1 | 0.82750778 |
| 66 | ERBB2 | 0.82437291 |
| 67 | ERBB3 | 0.81157927 |
| 68 | JAK2 | 0.81026543 |
| 69 | HIPK2 | 0.80995592 |
| 70 | PRPF4B | 0.80639663 |
| 71 | IKBKB | 0.80624573 |
| 72 | DYRK1B | 0.78658733 |
| 73 | JAK3 | 0.78569645 |
| 74 | SGK3 | 0.77206586 |
| 75 | MAP3K11 | 0.75374036 |
| 76 | FGFR2 | 0.74905960 |
| 77 | FES | 0.74895594 |
| 78 | PRKCI | 0.74627919 |
| 79 | TYK2 | 0.74298126 |
| 80 | CDK12 | 0.73810002 |
| 81 | PKN2 | 0.71577890 |
| 82 | PIK3CA | 0.71043242 |
| 83 | TAOK2 | 0.69202013 |
| 84 | MAPKAPK2 | 0.68397467 |
| 85 | KSR2 | 0.67670788 |
| 86 | WNK1 | 0.67536922 |
| 87 | MAP3K9 | 0.65894339 |
| 88 | PDK2 | 0.64916419 |
| 89 | SMG1 | 0.64860825 |
| 90 | EEF2K | 0.64413345 |
| 91 | JAK1 | 0.63940939 |
| 92 | NEK9 | 0.63613910 |
| 93 | NME1 | 0.61885926 |
| 94 | PAK4 | 0.61339695 |
| 95 | MAP3K14 | 0.59464671 |
| 96 | MAP3K13 | 0.59447932 |
| 97 | PRKD2 | 0.58999840 |
| 98 | BMPR2 | 0.57365594 |
| 99 | AKT3 | 0.55427727 |
| 100 | ZAK | 0.54210076 |
| 101 | MARK3 | 0.52329821 |
| 102 | MAP3K1 | 0.51836008 |
| 103 | CDC42BPA | 0.50347576 |
| 104 | ABL2 | 0.50063062 |
| 105 | TGFBR2 | 0.49835396 |
| 106 | RET | 0.49637196 |
| 107 | BMPR1B | 0.48966772 |
| 108 | GSK3A | 0.48056187 |
| 109 | IRAK3 | 0.47210702 |
| 110 | BMX | 0.47014066 |
| 111 | PRKD1 | 0.46769313 |
| 112 | BCR | 0.46673159 |
| 113 | PDPK1 | 0.45777497 |
| 114 | LATS2 | 0.44527439 |
| 115 | STK3 | 0.44235895 |
| 116 | MTOR | 0.44102076 |
| 117 | MAP3K5 | 0.42514750 |
| 118 | SGK2 | 0.41883178 |
| 119 | RPS6KA1 | 0.41400456 |
| 120 | SGK223 | 0.40067149 |
| 121 | SGK494 | 0.40067149 |
| 122 | FGFR3 | 0.39629840 |
| 123 | MATK | 0.39171848 |
| 124 | LCK | 0.38888479 |
| 125 | PRKG2 | 0.37929810 |
| 126 | PDK1 | 0.36467595 |
| 127 | ROCK1 | 0.35345227 |
| 128 | CHUK | 0.31450019 |
| 129 | NUAK1 | 0.30525392 |
| 130 | CSNK1D | 0.28595012 |
| 131 | EGFR | 0.28041612 |
| 132 | PRKCE | 0.27648382 |
| 133 | MAPK4 | 0.27561875 |
| 134 | NEK6 | 0.26172385 |
| 135 | RPS6KA4 | 0.26089349 |
| 136 | MAPKAPK5 | 0.25800781 |
| 137 | PDGFRB | 0.24871510 |
| 138 | ROCK2 | 0.24435712 |
| 139 | PRKAA2 | 0.24317176 |
| 140 | CSNK1A1 | 0.24246503 |
| 141 | NLK | 0.23849764 |
| 142 | PRKCA | 0.23795518 |
| 143 | IKBKE | 0.23531437 |
| 144 | CAMK2G | 0.23146893 |
| 145 | TBK1 | 0.22531627 |
| 146 | MAPK3 | 0.21180705 |
| 147 | TGFBR1 | 0.20731343 |
| 148 | RPS6KA2 | 0.19926659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.00474663 |
| 2 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.74621486 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.59829081 |
| 4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.28275116 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.05776442 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.94491060 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.48336012 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.41973493 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30888989 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.30618071 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.25456012 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23066303 |
| 13 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.01895501 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01132689 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93768046 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91446835 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87366259 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82849730 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.79465014 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78679823 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.77333129 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.75461060 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.75351712 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73865811 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.68806181 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68297287 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64804348 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62559763 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62364778 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62302452 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60961349 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60553776 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60001934 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58767643 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58113831 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56203060 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.53840579 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.53685148 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53507123 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51501223 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.50325605 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48857239 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48387085 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47611534 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41044316 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40642756 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39590936 |
| 48 | Measles_Homo sapiens_hsa05162 | 1.38598323 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37123886 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37044144 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.33597725 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30976870 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.27776743 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27341150 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26856806 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 1.26047515 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 1.23944024 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 1.23862036 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23727702 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23292065 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23288053 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.22643706 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22213060 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.18714456 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18370781 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17199780 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14527931 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13640504 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13469744 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12817325 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12751167 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10500762 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10430113 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.08448546 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07516066 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06503280 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.05791687 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03231336 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02929392 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02620964 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02144221 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 1.01988451 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01865152 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01419662 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98042261 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97165435 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96934244 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.96895837 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96844290 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.96104361 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.95571524 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93461293 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92920857 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.92288100 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92159005 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92108333 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90264334 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90220567 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88389376 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86306466 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84551964 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83593385 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.81137009 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80845568 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80377751 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79907639 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78038265 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77960160 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77081569 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75426795 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.74126515 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73990488 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72100042 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71546353 |
| 115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71426340 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69065526 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66906841 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65726450 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63214135 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.62440203 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62140670 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61792037 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.60808667 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60387367 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60303793 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59996502 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.59932915 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59470775 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59465972 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59352887 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59170508 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58701933 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58622855 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58518283 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57967725 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57257870 |
| 137 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56725976 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55882867 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53635837 |
| 140 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51111086 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51030890 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49206162 |
| 143 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45674100 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44809587 |
| 145 | Adherens junction_Homo sapiens_hsa04520 | 0.44089682 |
| 146 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43810427 |
| 147 | Bladder cancer_Homo sapiens_hsa05219 | 0.40296237 |
| 148 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38689309 |
| 149 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38501732 |
| 150 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36402742 |
| 151 | Hepatitis C_Homo sapiens_hsa05160 | 0.35548047 |
| 152 | Carbon metabolism_Homo sapiens_hsa01200 | 0.35075004 |
| 153 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34513356 |
| 154 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30863626 |
| 155 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29038523 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27642434 |
| 157 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26972182 |
| 158 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26401774 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25832514 |
| 160 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25645543 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.25588309 |
| 162 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22699508 |
| 163 | Lysine degradation_Homo sapiens_hsa00310 | 0.22119217 |
| 164 | Amoebiasis_Homo sapiens_hsa05146 | 0.20189856 |
| 165 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18732795 |
| 166 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.17748682 |
| 167 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17471106 |
| 168 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17448932 |
| 169 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14313469 |
| 170 | Axon guidance_Homo sapiens_hsa04360 | 0.13885490 |
| 171 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11876072 |
| 172 | Pertussis_Homo sapiens_hsa05133 | 0.11167115 |
| 173 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.10687511 |
| 174 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10069753 |
| 175 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08977928 |

